22157.jpg
Global Senolytic Drugs Market Research Report 2022: Voice of Customer, Clinical Trials, Patent Analysis, Outlook, Market Dynamics, Trends & Developments, Competitive Landscape
20 mai 2022 05h13 HE | Research and Markets
Dublin, May 20, 2022 (GLOBE NEWSWIRE) -- The "Global Senolytic Drugs Market, By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib &...
Merck Recognized for Responsible Entrepreneurship in the Netherlands
19 mai 2022 15h39 HE | Embassy of the Kingdom of the Netherlands
Washington, D.C., May 19, 2022 (GLOBE NEWSWIRE) -- On May 19, the Embassy of the Kingdom of the Netherlands presented the 2022 Holland on the Hill Heineken Award to New Jersey-based...
clarus_final_indentity.jpg
Clarus Therapeutics Announces Issuance of Patent Covering JATENZO® (testosterone undecanoate)
18 mai 2022 09h05 HE | Clarus Therapeutics Holdings, Inc.
JATENZO is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions Clarus plans to list this patent...
YSEOP_LOGO_FINAL-PURPLE-_-YELLOW (1).png
Yseop’s AI-Powered Augmented Analyst Chosen by Lilly to Expedite the Drug Approval Process and Deploy Automation at Scale
18 mai 2022 08h00 HE | Yseop
NEW YORK, May 18, 2022 (GLOBE NEWSWIRE) -- Yseop, a world-leading AI software company and pioneer in Natural Language Processing (NLP), today announced a strategic collaboration with Eli Lilly and...
AGC Biologics Invests in New Viral Vector Suspension Capabilities at U.S. Cell & Gene Hub
17 mai 2022 22h03 HE | AGC Biologics
SEATTLE, May 17, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it is adding viral vector...
BICX.jpg
BioCorRx Business Update for the First Quarter of 2022
17 mai 2022 08h30 HE | BioCorRx Inc
ANAHEIM, CA, May 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire  – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and...
22157.jpg
Global Polyclinics Market to 2027 - Featuring Optum, MCI Onehealth Technologies and Georgia Healthcare Among Others
17 mai 2022 05h03 HE | Research and Markets
Dublin, May 17, 2022 (GLOBE NEWSWIRE) -- The "Global Polyclinics Market, By Type (Large Scale Polyclinic v/s Express Clinic), By Services (Diagnostic, Consultation, Treatment), By Therapy Area, By...
lumos.png
Lumos Pharma to Participate in Upcoming Investor Conferences
16 mai 2022 16h05 HE | Lumos Pharma, Inc.
AUSTIN, Texas, May 16, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company...
clarus_final_indentity.jpg
Clarus Therapeutics Reports First Quarter 2022 Financial and Operating Results
16 mai 2022 16h05 HE | Clarus Therapeutics Holdings, Inc.
First quarter 2022 net revenue increased 72% year-over-year to $4.0 million First quarter 2022 total prescription growth for JATENZO® increased 12% sequentially and increased 75% year-over-year ...
Paul Mueller Company Logo
Paul Mueller Company Declares Quarterly Cash Dividend
13 mai 2022 18h00 HE | Paul Mueller Company
SPRINGFIELD, Mo., May 13, 2022 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) today announced that its Board of Directors has declared a cash dividend of 15 cents ($0.15) per share on its...